Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
He's Yangchao Granules
- Development stage
- Unknown
- Lead developer
- Hangzhou Hospital of Traditional Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
He's Yangchao Granules (何氏养巢颗粒) is a Traditional Chinese Medicine (TCM) compound preparation developed by the He's Gynecology department at Guangxing Hospital (affiliated with Zhejiang Chinese Medical University). The formula is rooted in the 'He's Gynecology' lineage, a recognized intangible cultural heritage in China. It is specifically indicated for the treatment of diminished ovarian reserve (DOR) and associated female infertility. The granules are intended to tonify the kidneys, nourish the blood, and regulate the Chong and Ren meridians, thereby improving ovarian response, increasing the number of retrieved oocytes, and enhancing pregnancy outcomes. Clinical research often evaluates its efficacy in combination with acupuncture.
- Brand names
- He's Yangchao Granules
- Other names
- 何氏养巢颗粒Heshi Yangchao KeliHe's Yangchao
Beyond the preview
Go deeper on He's Yangchao Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on He's Yangchao Granules.